The FDA has approved Avtozma® (tocilizumab-anoh), a biosimilar to Actemra®, in both intravenous and subcutaneous formulations.

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

ONAPGO is the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson's diseaseONAPGO is a wearable subcutaneous infusion devi ...

Once every four weeks maintenance dosing may be easier for patients and care partners to continue treatment Alzheimer's disease progression does not stop after plaque clearance; ongoing treatment with ...

A pharmacist is urging patients to reconsider weight loss injections after they were linked to fatalities in the UK.Between 2020 and 2024, 18 deaths suspected to be linked to weight loss injections ...

Fact checked by Nick Blackmer The recent approvals of Leqembi (lecanemab) and Kisunla (donanemab) have refreshed the landscape of Alzheimer’s disease treatments. For the first time, patients have the ...

Brendan Teehan named Chief Commercial Officer and Krys Corbett named Chief Business Officer ---- Key additions expected to support company’s ...

It is administered through intravenous and subcutaneous injection and act by targeting interferon beta 1 (IFNB1). GlobalData, the leading provider of industry intelligence, provided the underlying ...

“They often affect both herd profitability and animal welfare,” he said Injection-site lesions are typically made of scar tissue that forms in the muscle or subcutaneous tissue ... versus an ...

Heparin is administered via subcutaneous injection or intravenous infusion, depending on the condition. Major players include Baxter International's Optimvia, which offers both bovine and porcine ...

The precision of needle-free injections ensures effective medication delivery, for intramuscular and subcutaneous doses. This innovative approach has the potential to reduce the emotional toll on ...

The Ioniq 5 N DK Edition debuted at the Tokyo Auto Salon. Hyundai’s hottest ever production car—the Ioniq 5 N—has just been given a dose of ‘drifting’ steroids. And not by the fictional ...